Transgenic Mice with Constitutively Active M3 Muscarinic Receptor in Islet Beta Cells

Description:
Q490L point mutation was introduced into the rat M3 muscarinic receptor cDNA to confer persistent, constitutive (ligand-independent) activity. Expression of the M3 receptor mutant was placed under the control of a 650 bp fragment of the rat insulin promoter II (RIP II) to limit expression to the islet beta cell.
Patent Information:
For Information, Contact:
Mythreyi Shastri
Technology Development Specialist
NIH Technology Transfer
301-435-0613
shastrim@mail.nih.gov
Inventors:
Jurgen Wess
Keywords:
Active
Beta
Cells
CONSTITUTIVELY
IDXXXX
ISLET
IXXXXX
M3
Mice
MUSCARINIC
RECEPTOR
TRANSGENIC
© 2024. All Rights Reserved. Powered by Inteum